HEPION PHARMACEUTICALS INC

The current price of 336 is 1.32 EUR — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HEPION PHARMACEUTICALS INC stocks are traded under the ticker 336.

HEPION PHARMACEUTICALS INC is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

336 stock is 0% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is HEPION PHARMACEUTICALS INC there?

336 earnings for the last quarter are −2.98 EUR per share, whereas the estimation was −2.54 EUR resulting in a −17.54% surprise. The estimated earnings for the next quarter are −2.38 EUR per share. See more details about HEPION PHARMACEUTICALS INC earnings.

Yes, you can track HEPION PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.

336 net income for the last quarter is ‪−10.02 M‬ EUR, while the quarter before that showed ‪−9.96 M‬ EUR of net income which accounts for −0.62% change. Track more HEPION PHARMACEUTICALS INC financial stats to get the full picture.

Today HEPION PHARMACEUTICALS INC has the market capitalization of ‪6.99 M‬, it has decreased by 13.07% over the last week.

No, 336 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 336 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEPION PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.

336 reached its all-time high on May 23, 2023 with the price of 17.88 EUR, and its all-time low was 0.27 EUR and was reached on Dec 29, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has 22.00 employees. See our rating of the largest employees — is HEPION PHARMACEUTICALS INC on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEPION PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEPION PHARMACEUTICALS INC stock shows the strong sell signal. See more of HEPION PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.